Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma

Thorax

Volumn 54, Issue 6, 1999, Pages 488-492

  Hancox, Robert J ^c   Stevens, David A ^a   Adcock, Ian M ^a   Barnes, Peter J ^a   Taylor, D Robin ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c NONE

Author keywords

Inhaled corticosteroids; Transcription factors; 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IPRATROPIUM BROMIDE; TERBUTALINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; INHALER; PRIORITY JOURNAL; PROTEIN DNA BINDING; RANDOMIZED CONTROLLED TRIAL;

EID: 0013154785     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.6.488     Document Type: Article

References (26)

1. 1 Barnes PJ. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996;154:S21-7.
2. 2 Akerblom IE, Slater EP, Beato M, et al. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 1988;241:350-3.
3. 3 Imai E, Miner JN, Mitchell JA, et al. Glucocorticoid receptor-cAMP response element-binding protein and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993;268:5353-6.
4. 4 Janknecht R, Hunter T. Transcriptional control: versatile molecular glue. Curr Biol 1996;8:951-4.
5. 5 Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NFκB and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994;91:752-6.
6. 6 Adcock IM, Shirasaki H, Gelder CM, et al. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci 1994;55:1147-53.
7. 7 Mukaida N, Morita M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994;269:13289-95.
8. 8 Adcock IM, Brown CR, Gelder CM, et al. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 1995; 268:C331-8.
9. 9 Schüle R, Rangarajan P, Kliewer S, et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990;62:1217-26.
10. 10 Peters MJ, Adcock IM, Brown CR, et al. β-adrenoreceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 1995;289:275-81.
11. 11 Wong CS, Wahedna I, Pavord ID, et al. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med 1994;150:1268-73.
12. 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med 1995;152:1485-9.
13. 2-agonist, inhaled corticosteroid and their combination in the treatment of asthma. Thorax 1999;54: 482-7.
14. 14 Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
15. 15 Adcock IM, Lane SJ, Brown CR, et al. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 1995;182:1951-8.
16. 16 Workshop summary. Investigative use of bronchoscopy, lavage and bronchial biopsy in asthma and other airways diseases. Eur Respir J 1992;5:115-21.
17. 17 Rosewicz S, McDonald AR, Maddux BA. et al. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 1988;263:2581-4.
18. 18 Bellingham DL, Sar M, Cidlowski JA. Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol 1992;6:2090-102
19. 19 Korn SH, Wouters EFM, Wesseling G, et al. In vitro and in vivo modulation of α-and β-glucocorticoid receptor mRNA in human bronchial epithelium. Am J Respir Crit Care Med 1997;155:1117-22.
20. 20 Kalinyak JE, Dorin RI, Hoffman AR, et al. Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone. J Biol Chem 1987;262:10441-4.
21. 21 Svec F. The biopotency of dexamethasone at causing hepatic glucocorticoid receptor down-regulation in the intact mouse. Biochem Biophys Acta 1988;970:90-5.
22. 22 Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994;10:405-55.
23. 23 Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-90.
24. 24 Scheinman RI, Cogswell PC, Lofquist AK, et al. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.
25. 25 Brostjan C, Anrather J, Csizmadia V, et al. Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBα synthesis. J Biol Chem 1996;271:19612-6.
26. 26 Heck S, Bender K, Kullmann M, et al. IκBα-independant downregulation of NF-κB activity by glucocorticoid receptor. EMBO J 1997;16:4698-707.